Skip to main content
TVTX
NASDAQ Life Sciences

Officer Eric Dube Files Intent to Sell $1.8M in Stock Amidst Ongoing Insider Distribution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$30.39
Mkt Cap
$2.719B
52W Low
$12.91
52W High
$42.13
52W Position info
135% above low
Off High info
28% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

TVTX has more than doubled off its 52-week low of $12.91.

Summary

Officer Eric M. Dube has filed a Form 144 indicating intent to sell 60,000 shares of Travere Therapeutics common stock, valued at approximately $1.8 million, continuing a pattern of insider share disposition.


Key Events · Ownership and Investor Activity · TVTX

  • Proposed Stock Sale

    Officer Eric M. Dube intends to sell 60,000 shares of common stock, valued at approximately $1.8 million.

  • Ongoing Insider Distribution

    This filing follows previous sales by Mr. Dube totaling over $5 million in the last three months, indicating a sustained pattern of share disposition.

  • Officer-Level Transaction

    The filer, Eric M. Dube, holds an officer position within Travere Therapeutics, Inc.


Analysis · TVTX · Life Sciences

This Form 144 filing by Officer Eric M. Dube signals a continued pattern of share distribution by the insider, following previous sales totaling over $5 million in the past three months. While the proposed sale of $1.8 million is a relatively small percentage of the company's market capitalization, the consistent insider selling by an officer could be perceived negatively by investors, especially coming shortly after the company's 10-K filing highlighted strong financial performance. This ongoing distribution suggests a reduction in insider exposure.

How filings like this one have moved

In the 30 days to Nov 11, 2026, 36.6% of the 3434 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TVTX was trading at $30.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $12.91 to $42.13. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TVTX - Latest Insights

TVTX
Nov 02, 2026, 4:01 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $49.26
Real-time Price: $51.81 info
Change: +$2.55 (+5%) info
Market Cap: $4.973B info
TVTX
Oct 02, 2026, 10:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $56.55
Real-time Price: $51.81 info
Change: -$4.74 (-8%) info
Market Cap: $4.973B info
TVTX
Sep 21, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $62.63
Real-time Price: $51.81 info
Change: -$10.82 (-17%) info
Market Cap: $4.973B info
TVTX
Aug 04, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $63.55
Real-time Price: $51.81 info
Change: -$11.74 (-18%) info
Market Cap: $4.973B info
TVTX
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $62.00
Real-time Price: $51.81 info
Change: -$10.19 (-16%) info
Market Cap: $4.973B info